SCHEMBL3852141

SCHEMBL3852141

c1ccc(C(c2ccccc2)(c2ccccc2)n2ccc(-c3ccccn3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.47
LMNA P02545 5/20 0.47
CCR1 P32246 3/20 0.47
CCR5 P51681 3/20 0.47
CCR8 P51685 3/20 0.47
CYP1A2 P05177 1/20 0.47
POLB P06746 1/20 0.47
METAP1 P53582 1/20 0.47
BLM P54132 1/20 0.47
HIF1A Q16665 1/20 0.47
DOHH Q9BU89 1/20 0.47
P4HTM Q9NXG6 1/20 0.47
L3MBTL1 Q9Y468 4/20 0.41
TP53 P04637 4/20 0.41
NPC1 O15118 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
RAB9A P51151 3/20 0.41
ALOX15 P16050 2/20 0.41
HTT P42858 2/20 0.41
TDP1 Q9NUW8 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17658860 0.79 KDM4E (0.50) KDM4ELMNACCR1CCR5CCR8
SCHEMBL5800759 0.79 KMT2A (0.52) KDM4EL3MBTL1TP53NPC1SMN1; SMN2
SCHEMBL4240350 0.78 MAP4K4 (0.40) KDM4EL3MBTL1CYP11B1CYP11B2KCNN4
SCHEMBL19122116 0.77 KDM4E (0.47) KDM4ELMNACCR1CCR5CCR8
SCHEMBL9404829 0.77 DYRK1A (0.42) KDM4ELMNACYP1A2BLMHIF1A
SCHEMBL23034546 0.73 KDM4E (0.42) KDM4ELMNACCR1CCR5CCR8
SCHEMBL9383743 0.71 KDM4E (0.58) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL27971550 0.71 KDM4E (0.93) KDM4ELMNACCR1CCR5CCR8
SCHEMBL2194189 0.69 CYP11B1 (0.40) LMNACYP1A2BLMHIF1AL3MBTL1
SCHEMBL14478094 0.69 CYP11B1 (0.40) KDM4ELMNACYP1A2BLMHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed